- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Aegerion Pharmaceuticals (NASDAQ:AEGR): Aegerion backs its FY13 revenue of $15 million to $25 million, consensus $22.02 million. The shares closed at $36.12, up $1.65 or 4.79 percent on the day. They have traded in a 52-week range of $11.75 to $34.82.
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.